Literature DB >> 977765

Changing blood picture in sickle-cell anaemia from shortly after birth to adolescence.

L R Davis.   

Abstract

The blood picture of children with sickle-cell anaemia was found to change with age. The changes were most marked in the first year but the mean level of haemoglobin, haemoglobin F, and target cells fell until adolescence, and irreversibly sickled cells rose. Reticulocytes, Howell Jolly bodies, and normablasts altered little after one year. The fall in haemoglobin F suggested a delayed changeover from fetal to adult haemoglobin production. It was concluded that the blood changes in sickle-cell anaemia were progressive throughout childhood.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977765      PMCID: PMC476210          DOI: 10.1136/jcp.29.10.898

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

1.  In vivo study of the sickle cell phenomenon.

Authors:  W N JENSEN; D L RUCKNAGEL; W J TAYLOR
Journal:  J Lab Clin Med       Date:  1960-12

2.  Amelioration of sickle cell disease by persistent fetal hemoglobin.

Authors:  J F JACKSON; J L ODOM; W N BELL
Journal:  JAMA       Date:  1961-09-23       Impact factor: 56.272

3.  Studies on abnormal hemoglobins. I. Their demonstration in sickle cell anemia and other hematologic disorders by means of alkali denaturation.

Authors:  K SINGER; A I CHERNOFF; L SINGER
Journal:  Blood       Date:  1951-05       Impact factor: 22.113

4.  Irreversibly sickled cells and splenomegaly in sickle-cell anaemia.

Authors:  G R Serjeant
Journal:  Br J Haematol       Date:  1970-11       Impact factor: 6.998

5.  Functional asplenia in sickle-cell anemia.

Authors:  H A Pearson; R P Spencer; E A Cornelius
Journal:  N Engl J Med       Date:  1969-10-23       Impact factor: 91.245

6.  Target cells in haemoglobinopathies.

Authors:  L R Davis
Journal:  J Clin Pathol       Date:  1972-02       Impact factor: 3.411

  6 in total
  8 in total

1.  Heterogeneity of sickle-cell anemia based on a profile of hematological variables.

Authors:  D J Odenheimer; C F Whitten; D L Rucknagel; S A Sarnaik; C F Sing
Journal:  Am J Hum Genet       Date:  1983-11       Impact factor: 11.025

2.  Sickle-cell anaemia in infancy.

Authors: 
Journal:  Br Med J       Date:  1978-06-03

3.  T1 and T2 values of human neonatal blood at 3 Tesla: Dependence on hematocrit, oxygenation, and temperature.

Authors:  Peiying Liu; Lina F Chalak; Lisa C Krishnamurthy; Imran Mir; Shin-lei Peng; Hao Huang; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2015-05-18       Impact factor: 4.668

4.  Fetal hemoglobin during infancy and in sickle cell adults.

Authors:  Dominic Edoh; Charles Antwi-Bosaiko; Dominic Amuzu
Journal:  Afr Health Sci       Date:  2006-03       Impact factor: 0.927

5.  Mathematical Modeling of Hydroxyurea Therapy in Individuals with Sickle Cell Disease.

Authors:  Akancha Pandey; Jeremie H Estepp; Rubesh Raja; Guolian Kang; Doraiswami Ramkrishna
Journal:  Pharmaceutics       Date:  2022-05-16       Impact factor: 6.525

6.  Sickle cell disease in Saudi Arabs in early childhood.

Authors:  R P Perrine; P John; M Pembrey; S Perrine
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

7.  Sickle cell haemoglobinopathies in England.

Authors:  J R Mann
Journal:  Arch Dis Child       Date:  1981-09       Impact factor: 3.791

8.  From infancy to adolescence: fifteen years of continuous treatment with hydroxyurea in sickle cell anemia.

Authors:  Jane S Hankins; Banu Aygun; Kerri Nottage; Courtney Thornburg; Matthew P Smeltzer; Russell E Ware; Winfred C Wang
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.